Clinical trial of etomidate
- 144 Downloads
This is a preliminary report of our clinical experience with etomidate, a new intravenous non-barbiturate anaesthetic agent. Thirty-two patients undergoing minor surgical procedures were anaesthetized, induction being with etomidate 0.3 mg/kg body weight. Induction was fast and smooth. Twenty-eight per cent of the patients complained of pain at site of injection but the pain disappeared on flushing with water for injection. Following etomidate injection, 37.5 per cent of patients developed myoclonic movements which were usually mild and self-limiting. We were impressed by the relative stability of the cardiovascular and respiratory systems. Etomidate looks promising and further work is in progress on other aspects of this drug.
KeywordsMeperidine Etomidate CANADIAN Anaesthetist Porphyria Methohexital
- 1.Janssen, P.A.J., Niemegeers, C.J.E., Schellekens, K.H.L., &Lenaerts, F.M. Etomidate, R -(+) -Ethyl-1- (α-methylbenzyl)imidazole-5-carboxylate (R16659). Arzneimittelforsh. (Drug Res.)21: 1234 (1971).Google Scholar
- 2.Doenicke, A. Clinical experimental studies and first report on clinical experience with a new I.V. hypnotic. Proceedings of the 6th International Refresher course on Clinical Anaesthesiology, Vienna, May 21–25, 1973.Google Scholar
- 3.Doenicke, A., Gabanyi, D., Lemche, H., &Schurk-Bulichim. Circulatory behaviour and myocardial function after administration of three short I.V. hypnotics — etomidate, propanidid, and methohexital. Anaesthetist23: 108–115 (1974).Google Scholar
- 4.Gooding, J.M. &Corseen, D.G. Etomidate: An ultrashort-acting non-barbiturate agent for anaesthesia induction. Anaesthesia and Analgesia Current Researches, Vol. 55, No. 2 (March-April, 1976).Google Scholar